Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

  1. Llovera, M.
  2. Pichard, C.
  3. Bernichtein, S.
  4. Jeay, S.
  5. Touraine, P.
  6. Kelly, P.A.
  7. Goffin, V.
Revue:
Oncogene

ISSN: 0950-9232

Année de publication: 2000

Volumen: 19

Número: 41

Pages: 4695-4705

Type: Article

DOI: 10.1038/SJ.ONC.1203846 GOOGLE SCHOLAR

Objetivos de desarrollo sostenible

La source de données: Scopus